Photo from wikipedia
Despite 5-year overall survival rate of breast cancer was 90%, approximately 30% breast cancer patients with an early-stage diagnosis eventually progressed to advanced metastatic disease, and about 6% of patients… Click to show full abstract
Despite 5-year overall survival rate of breast cancer was 90%, approximately 30% breast cancer patients with an early-stage diagnosis eventually progressed to advanced metastatic disease, and about 6% of patients were metastatic disease at diagnosis (1). Treatments of advanced breast cancer include chemotherapy, endocrine-based therapeutic strategies, HER2-related regimens, CDK4/6 inhibitors and Original Article
Keywords:
safety inhibitors;
efficacy safety;
inhibitors breast;
breast cancer;
cancer;
cancer systematic
Journal Title: Translational cancer research
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Translational cancer research
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!